• Globe Newswire

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2250a8861042&size=3[/img]

• Globe Newswire

Philips announces exchange ratio for 2023 dividend

• Globe Newswire

Philips shareholders approve all proposals at the AGM 2024

• Globe Newswire

Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion

• Globe Newswire

Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward

• Globe Newswire

Philips convenes the Annual General Meeting of Shareholders 2024

• Globe Newswire

Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office